MedPath

A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures

Not Applicable
Completed
Conditions
Tibial Fractures
Interventions
Device: reamed, interlocking intramedullary nail
Device: locking periarticular plate
Registration Number
NCT00429585
Lead Sponsor
Boston Medical Center
Brief Summary

This study looks at two types of surgical treatments and hopes to answer the question: which is the best way to surgically treat a proximal tibia fracture? Both procedures being studied are standard of care (used routinely) and use FDA approved devices. All medical and surgical treatment will be the same for participants as non-participants.

Detailed Description

The study is a multicenter randomized controlled trial in which individuals sustaining a fracture of the proximal metaphysis of the tibia will be operatively managed by one of two strategies. The first strategy involves fixation of the fracture with a reamed, interlocking intramedullary nail (Nail Group). The second treatment strategy involves open reduction and internal fixation of the fracture with a locking periarticular plate (Plate Group). The null hypothesis of the study is that there will be no difference in the two groups with respect to the primary and secondary outcome measures. To the degree possible, patients in the two groups will receive post-operative care according to the same standards and protocols.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • Skeletally mature,
  • Extra-articular fracture of the proximal tibia extending into the metaphyseal with or without intra-articular extension not requiring open reduction with complete anteroposterior (AP) and lateral radiographs,
  • Major fracture line not closer than 4cm from the proximal tibial articular surface
  • Fracture requiring operative treatment amenable to either IM nail or plate
  • Surgeon agreed to randomize patient
  • Informed consent obtained
  • Patient is English speaking
Exclusion Criteria
  • Tibial shaft fractures not amenable to intramedullary nailing (i.e.fracture is less than 4 cm from joint surface),
  • Fracture of the proximal tibia with intraarticular extension requiring open reduction,
  • Known metabolic bone disease
  • Separate displaced tibial tubercle fragment,
  • Soft tissue injuries compromising treatment method with nail,plate or both.
  • Fractures with vascular injury (Gustillo Type IIIC injury) requiring repair,
  • Compartment syndrome of the leg diagnosed preoperatively,
  • Pathological fractures,
  • Retained hardware or existing deformity in the affected limb that would complicate IM nailing,plating or both,
  • Symptomatic knee arthritis.
  • Surgical delay greater than 3 weeks for closed fractures or 24 hours for open fractures,
  • Immunocompromised,
  • Unable to comply with postoperative rehabilitation protocols or instructions (i.e. head injured or mentally impaired),
  • Current or impending incarceration,
  • Unlikely to follow-up in surgeon's estimation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Randomized Treatment - Nailreamed, interlocking intramedullary nailRandomized Treatment - Nail
Randomized Treatment - Platelocking periarticular plateRandomized Treatment - Plate
Primary Outcome Measures
NameTimeMethod
Participants' Quality of Life at 3 Months3 months

The European Quality of Life Five Dimension (EQ-5D) Survey will be used to measure the participants' quality of life. The EQ-5D measures the subjects' overall state, including 5 domains: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: 1= no problems, 2= slight problems, 3=moderate problems, 4=severe problems and 5=extreme problems. The score is determined by a scale and grading systems that can range from 0.01 to 1.00. The lower the score the less quality of life problems.

Participants' Quality of Life at 6 Months6 months

The European Quality of Life Five Dimension (EQ-5D) Survey will be used to measure the participants' quality of life. The EQ-5D measures the subjects' overall state, including 5 domains: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: 1= no problems, 2= slight problems, 3=moderate problems, 4=severe problems and 5=extreme problems. The score is determined by a scale and grading systems that can range from 0.01 to 1.00. The lower the score the less quality of life problems.

Participants' Quality of Life at 12 Months12 months

The European Quality of Life Five Dimension (EQ-5D) Survey will be used to measure the participants' quality of life. The EQ-5D measures the subjects' overall state, including 5 domains: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: 1= no problems, 2= slight problems, 3=moderate problems, 4=severe problems and 5=extreme problems. The score is determined by a scale and grading systems that can range from 0.01 to 1.00. The higher the score the less quality of life problems.

Injury Related Limitations and Concerns at 6 Months6 months

Participant limitations and bother from the injury will be assessed using the Short Musculoskeletal Function Assessment (SMFA).This survey asks the subject 46 questions, they are broken up into 2 parts. Part 1 relates to the difficulty/limitations the subject has related to their injury. Part 2 is how much the subject is bothered by this injury. Subjects provide score on a scale of 1 (no difficulty/bother) to 5 (highly difficult/bothered). The scoring range is between 0-100. The lower the score the less injury related limitations and bother.

Injury Related Limitations and Concerns at 3 Months3 months

Participant limitations and bother from the injury will be assessed using the Short Musculoskeletal Function Assessment (SMFA).This survey asks the subject 46 questions, they are broken up into 2 parts. Part 1 relates to the difficulty/limitations the subject has related to their injury. Part 2 is how much the subject is bothered by this injury. Subjects provide score on a scale of 1 (no difficulty/bother) to 5 (highly difficult/bothered). The scoring range is between 0-100. The lower the score the less injury related limitations and bother.

Injury Related Limitations and Concerns at 12 Months12 month follow-up

Participant limitations and bother from the injury will be assessed using the Short Musculoskeletal Function Assessment (SMFA).This survey asks the subject 46 questions, they are broken up into 2 parts. Part 1 relates to the difficulty/limitations the subject has related to their injury. Part 2 is how much the subject is bothered by this injury. Subjects provide score on a scale of 1 (no difficulty/bother) to 5 (highly difficult/bothered). The scoring range is between 0-100. The lower the score the less difficulty and bother.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Malunion (>5 Degrees Varus/Valgus)12 months

Malunion is when a broken bone heals in an abnormal position. In this case, more than a 5 degree angle varus (curving into) or valgus (curving away). This is determined by a review of the participants' medical records and x-rays.

Number of Participants With Fracture Nonunions12 months

A nonunion is when a broken bone fails to heal. This is determined by a review of the participants' medical records and x-rays.

Number of Participants With Deep Infections6 months

A deep infection is an infection occurring at the site of the nail or plate. Participants are monitored during clinical exams throughout the 12 month follow up appointments and medical records are reviewed.

Number of Participants With Superficial Infections6 months

A superficial infection is an infection that occurs at the wound only. Participants are monitored during clinical exams throughout the 12 month follow up appointments and medical records are reviewed.

Number of Participants With Compartment Syndrome6 months

Compartment syndrome is a painful condition that occurs when pressure within the muscles builds to dangerous levels. Participants are monitored during clinical exams throughout the 12 month follow up appointments and medical records are reviewed.

Trial Locations

Locations (29)

University Of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

St. Michaels Hospital - Toronto

🇨🇦

Toronto, Ontario, Canada

Harborview Medical Center

🇺🇸

Seattle, Washington, United States

Indiana University

🇺🇸

Indianapolis, Indiana, United States

IU Health Methodist Hospital

🇺🇸

Indianapolis, Indiana, United States

Hennepin County Medical Center

🇺🇸

Minneapolis, Minnesota, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

University of California at Davis

🇺🇸

Davis, California, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

University of Maryland Medical Center

🇺🇸

Baltimore, Maryland, United States

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

UMass Memorial Medical Center

🇺🇸

Worcester, Massachusetts, United States

University of Michigan Hospital

🇺🇸

Ann Arbor, Michigan, United States

St. Louis University Hospital

🇺🇸

Saint Louis, Missouri, United States

Barnes Hospital

🇺🇸

Saint Louis, Missouri, United States

Cooper University Hospital

🇺🇸

Camden, New Jersey, United States

New York Hospital for Joint Diseases

🇺🇸

New York, New York, United States

Campbell Foundation

🇺🇸

Memphis, Tennessee, United States

Orthopaedic Specialty Associates - Fort Worth

🇺🇸

Fort Worth, Texas, United States

Victoria Hospital

🇨🇦

London, Ontario, Canada

Orthopaedic Associates of Michigan

🇺🇸

Grand Rapids, Michigan, United States

University of Alabama - Burmingham

🇺🇸

Birmingham, Alabama, United States

University of California-San Francisco

🇺🇸

San Francisco, California, United States

St. Mary's Hospital - Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

University of Oklahoma/ Health Science

🇺🇸

Oklahoma City, Oklahoma, United States

Oregon health and science university

🇺🇸

Portland, Oregon, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath